CONMED Corporation

CONMED Corporation

CNMD
CONMED CorporationUS flagNew York Stock Exchange
33.06
USD
-0.79
- -
995.41MMarket Cap

Total Valuation

CONMED Corporation carries a market capitalization of 995.41M, placing it among publicly traded companies globally. Its enterprise value stands at 1.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap995.41M
Enterprise Value1.92B

Share Statistics

CONMED Corporation currently has 30.14M shares outstanding.

Shares Outstanding30.14M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

CONMED Corporation trades at a trailing price-to-earnings ratio of 19.90. The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 1.81.

PE Ratio19.90
PS Ratio0.80
PB Ratio1.81
P/TBV Ratio-3.01
P/FCF Ratio6.77
P/OCF Ratio7.65

Enterprise Valuation

On an enterprise value basis, CONMED Corporation trades at an EV/EBITDA multiple of 10.26 and an EV/FCF ratio of 10.56. The EV/Sales ratio of 1.40 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.11 provides insight into valuation relative to core operating earnings.

EV / Sales1.40
EV / EBITDA10.26
EV / EBIT17.11
EV / FCF10.56

Financial Position

CONMED Corporation maintains a current ratio of 2.29, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 84.59, indicating elevated leverage, while an interest coverage ratio of 6.26 demonstrates adequate ability to service its debt obligations.

Current Ratio2.29
Quick Ratio0.90
Debt / Equity84.59
Debt / EBITDA4.60
Interest Coverage6.26

Financial Efficiency

CONMED Corporation posts a return on equity of 9.43 and a return on invested capital of 4.01.

Return on Equity (ROE)9.43
Return on Assets (ROA)2.38
Return on Invested Capital (ROIC)4.01
Return on Capital Employed (ROCE)5.13
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.70

Taxes

Over the trailing twelve months, CONMED Corporation has paid 26.95M in income taxes, reflecting an effective tax rate of 32.95.

Income Tax26.95M
Effective Tax Rate32.95

Stock Price Statistics

CONMED Corporation's stock has declined approximately -41.90828% over the past 52 weeks. The 50-day moving average sits at 36.58, while the 200-day moving average is 42.56.

Beta (5Y)N/A
52-Week Price Change-41.90828%
50-Day Moving Average36.58
200-Day Moving Average42.56
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, CONMED Corporation generated 1.37B in revenue and converted that into 54.85M in net income, yielding earnings per share of 1.77. EBITDA reached 186.94M, while operating income came in at 112.08M.

Revenue1.37B
Gross Profit756.17M
Operating Income112.08M
Pretax Income81.80M
Net Income54.85M
EBITDA186.94M
EBIT112.08M
Earnings Per Share (EPS)1.77

Balance Sheet

CONMED Corporation holds 35.03M in cash and equivalents against 860.87M in total debt, resulting in a net debt position of 825.84M. Total book value stands at 602.91M, with working capital of 377.88M providing operational flexibility.

Cash & Cash Equivalents35.03M
Total Debt860.87M
Net Debt825.84M
Equity (Book Value)602.91M
Book Value Per Share19.53
Working Capital377.88M

Cash Flow

CONMED Corporation produced 142.63M in operating cash flow over the past twelve months. After subtracting -18.92M in capital expenditures, free cash flow totaled 123.71M - equivalent to 4.01 per share.

Operating Cash Flow142.63M
Capital Expenditures-18.92M
Free Cash Flow123.71M
FCF Per Share4.01

Margins

CONMED Corporation operates with a gross margin of 55.17, reflecting its pricing power and cost economics. The operating margin of 8.18 and net profit margin of 4.00 provide insight into operational efficiency.

Gross Margin55.17
Operating Margin8.18
Pretax Margin5.97
Profit Margin4.00
EBITDA Margin13.64

Dividends & Yields

The company's payout ratio of 33.85 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.60
Dividend YieldN/A
Payout Ratio33.85
Shareholder Yield11.91
FCF Yield14.77

Stock Splits

CONMED Corporation's most recent stock split took place on September 10, 2001 with a 2:3 split ratio.

Last Split Date9/10/2001
Split Ratio2:3

Scores

CONMED Corporation posts an Altman Z-Score of 3.76, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.76